The oilman who invests in SmithKline because his broker suggests it won’t realize that patients have abandoned Tagamet and switched to a rival ulcer drug until the stock is down 40 percent and the bad news has been fully “discounted” in the price. “Discounting” is a Wall Street euphemism for pretending to have anticipated surprising developments.
